Delving into the Latest Updates on Na-ASP-2 Hookworm Vaccine(Albert B. Sabin Vaccine Institute) with Synapse

Overview

Basic Info

Drug Type

Prophylactic vaccine

Synonyms-

Target-

Action-

Mechanism-

Therapeutic Areas-

Active Indication-

Inactive Indication-

Originator Organization

Albert B. Sabin Vaccine Institute, Inc.

Active Organization-

Inactive Organization-

License Organization-

Drug Highest Phase-

First Approval Date-

Regulation-

Login to view timeline

Na-ASP-2 is a protein expressed during the larval stage of the N. americanus hookworm life cycle. Vaccination with recombinant ASP-2 has protected dogs and hamsters from infection in challenge studies. In a clinical study in hookworm-uninfected adults in the USA, Na-ASP-2 Hookworm Vaccine was safe and immunogenic. This study will evaluate its safety and immunogenicity in individuals living in an area of endemic hookworm infection.

Start Date01 May 2007

Sponsor / Collaborator

Albert B. Sabin Vaccine Institute, Inc.

[+3]

100 Clinical Results associated with Na-ASP-2 Hookworm Vaccine(Albert B. Sabin Vaccine Institute)

Login to view more data

100 Translational Medicine associated with Na-ASP-2 Hookworm Vaccine(Albert B. Sabin Vaccine Institute)

Login to view more data

100 Patents (Medical) associated with Na-ASP-2 Hookworm Vaccine(Albert B. Sabin Vaccine Institute)

Login to view more data

100 Deals associated with Na-ASP-2 Hookworm Vaccine(Albert B. Sabin Vaccine Institute)

Login to view more data